Literature DB >> 30791186

Adipose tissue-derived mesenchymal stem cells and keratinocytes co-culture on gelatin/chitosan/β-glycerol phosphate nanoscaffold in skin regeneration.

Marzieh Lotfi1,2, Hojjat Naderi-Meshkin3, Elahe Mahdipour4, Asghar Mafinezhad5, Roohollah Bagherzadeh6, Hamid Reza Sadeghnia7, Habibollah Esmaily8, Masoud Maleki9, Halimeh Hasssanzadeh3, Majid Ghayaour-Mobarhan10, Hamid Reza Bidkhori3, Ahmad Reza Bahrami3,11.   

Abstract

Using cell-based engineered skin is an emerging strategy for treating difficult-to-heal wounds. To date, much endeavor has been devoted to the fabrication of appropriate scaffolds with suitable biomechanical properties to support cell viability and growth in the microenvironment of a wound. The aim of this research was to assess the impact of adipose tissue-derived mesenchymal stem cells (AD-MSCs) and keratinocytes on gelatin/chitosan/β-glycerol phosphate (GCGP) nanoscaffold in full-thickness excisional skin wound healing of rats. For this purpose, AD-MSCs and keratinocytes were isolated from rats and GCGP nanoscaffolds were electrospun. Through an in vivo study, the percentage of wound closure was assessed on days 7, 14, and 21 after wound induction. Samples were taken from the wound sites in order to evaluate the density of collagen fibers and vessels at 7 and 14 days. Moreover, sampling was done on days 7 and 14 from wound sites to assess the density of collagen fibers and vessels. The wound closure rate was significantly increased in the keratinocytes-AD-MSCs-scaffold (KMS) group compared with other groups. The expressions of vascular endothelial growth factor, collagen type 1, and CD34 were also significantly higher in the KMS group compared with the other groups. These results suggest that the combination of AD-MSCs and keratinocytes seeded onto GCGP nanoscaffold provides a promising treatment for wound healing.
© 2019 International Federation for Cell Biology.

Entities:  

Keywords:  adipose-derived mesenchymal stem cells (AD-MSCs); chitosan; keratinocyte; nanoscaffold; wound healing

Year:  2019        PMID: 30791186     DOI: 10.1002/cbin.11119

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  6 in total

Review 1.  Stem cell-based therapy for human diseases.

Authors:  Duc M Hoang; Phuong T Pham; Trung Q Bach; Anh T L Ngo; Quyen T Nguyen; Trang T K Phan; Giang H Nguyen; Phuong T T Le; Van T Hoang; Nicholas R Forsyth; Michael Heke; Liem Thanh Nguyen
Journal:  Signal Transduct Target Ther       Date:  2022-08-06

Review 2.  Enhancing Stem Cell-Based Therapeutic Potential by Combining Various Bioengineering Technologies.

Authors:  In-Sun Hong
Journal:  Front Cell Dev Biol       Date:  2022-07-05

3.  Preparation, characterization and evaluation of a new film based on chitosan, arginine and gold nanoparticle derivatives for wound-healing efficacy.

Authors:  Kai Wang; Zhiping Qi; Su Pan; Shuang Zheng; Haosheng Wang; YuXin Chang; Hongru Li; Pan Xue; Xiaoyu Yang; Chuan Fu
Journal:  RSC Adv       Date:  2020-06-02       Impact factor: 4.036

Review 4.  State-of-the-Art Review of Electrospun Gelatin-Based Nanofiber Dressings for Wound Healing Applications.

Authors:  Tao Li; Mingchao Sun; Shaohua Wu
Journal:  Nanomaterials (Basel)       Date:  2022-02-25       Impact factor: 5.076

5.  Epithelial differentiation of human adipose-derived stem cells (hASCs) undergoing three-dimensional (3D) cultivation with collagen sponge scaffold (CSS) via an indirect co-culture strategy.

Authors:  Minxiong Li; Jun Ma; Yanbin Gao; Mengru Dong; Zijun Zheng; Yuchen Li; Rongwei Tan; Zhending She; Lei Yang
Journal:  Stem Cell Res Ther       Date:  2020-03-31       Impact factor: 6.832

Review 6.  Principal Criteria for Evaluating the Quality, Safety and Efficacy of hMSC-Based Products in Clinical Practice: Current Approaches and Challenges.

Authors:  Juan Antonio Guadix; Javier López-Beas; Beatriz Clares; José Luis Soriano-Ruiz; José Luis Zugaza; Patricia Gálvez-Martín
Journal:  Pharmaceutics       Date:  2019-10-24       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.